UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

18 F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer

Translational oncology, 2013, Vol.6 (5), p.586-IN7

2013

Volltextzugriff (PDF)

Acquisition of chemoresistance in a human ovarian carcinoma cell line is linked to a defect in cell cycle control

International journal of cancer, 1998-11, Vol.78 (4), p.454-463

1998

Volltextzugriff (PDF)

Altered adhesion properties and alpha v integrin expression in a cisplatin‐resistant human ovarian carcinoma cell line

International journal of cancer, 2002-01, Vol.97 (2), p.186-194

2002

Volltextzugriff (PDF)

Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route

Oncology reports, 2017-10, Vol.38 (4), p.1949-1958

2017

Volltextzugriff (PDF)

Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumour drugs

Anti-cancer drug design, 2000-04, Vol.15 (2), p.109

2000

Volltextzugriff (PDF)

Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulation

Apoptosis (London), 2015-04, Vol.20 (4), p.535-550

2015

Volltextzugriff (PDF)

Citrate induces apoptotic cell death: a promising way to treat gastric carcinoma?

Anticancer research, 2011-03, Vol.31 (3), p.797-805

2011

Volltextzugriff (PDF)

Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma

Journal of experimental & clinical cancer research, 2023-10, Vol.42 (1), p.1-260, Article 260

2023

Volltextzugriff (PDF)

The cyclin-dependent kinase inhibitor p21(cip1/waf1) enhances the cytotoxicity of ganciclovir in HSV-tk transfected ovarian carcinoma cells

Cancer letters, 2004-08, Vol.212 (1), p.43

2004

Volltextzugriff (PDF)

Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells

Oncotarget, 2016-06, Vol.7 (24), p.35753-35767

2016

Volltextzugriff (PDF)

Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease

European journal of nuclear medicine and molecular imaging, 2009-03, Vol.36 (3), p.396-405

2009

Volltextzugriff (PDF)

Effect of 2-Deoxy-D-glucose on Various Malignant Cell Lines In Vitro

Anticancer research, 2006-09, Vol.26 (5A), p.3561-3566

2006

Volltextzugriff (PDF)

Effect of Citrate on Malignant Pleural Mesothelioma Cells: A Synergistic Effect with Cisplatin

Anticancer research, 2009-04, Vol.29 (4), p.1249-1254

2009

Volltextzugriff (PDF)

Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant Recipients

Advances in therapy, 2023-09, Vol.40 (9), p.3956-3970

2023

Volltextzugriff (PDF)

Functional miRNA screening identifies wide-ranging antitumor properties of miR-3622b-5p and reveals a new therapeutic combination strategy in ovarian tumor organoids

Molecular cancer therapeutics, 2020-07, Vol.19 (7), p.1506-1519

2020

Volltextzugriff (PDF)

Identification of predictive factors of response to the BH3‐mimetic molecule ABT‐737: An ex vivo experiment in human serous ovarian carcinoma

International journal of cancer, 2015-03, Vol.136 (5), p.E340-E350

2015

Volltextzugriff (PDF)

Identifying patients eligible for PARP inhibitor treatment: from NGS-based tests to 3D functional assays

British journal of cancer, 2021-07, Vol.125 (1), p.7-14

2021

Volltextzugriff (PDF)

Impact of automated methods for quantitative evaluation of immunostaining: Towards digital pathology

Frontiers in oncology, 2022-10, Vol.12, p.931035-931035

2022

Volltextzugriff (PDF)

The influence of long non-coding RNAs on the response to chemotherapy in ovarian cancer

Gynecologic oncology, 2020-03, Vol.156 (3), p.726-733

2020

Volltextzugriff (PDF)

Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin

Tumor biology, 2010-04, Vol.31 (2), p.129-139

2010

Volltextzugriff (PDF)

Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk

Journal of experimental & clinical cancer research, 2023-07, Vol.42 (1), p.173-173, Article 173

2023

Volltextzugriff (PDF)

The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels

Molecular oncology, 2021-12, Vol.15 (12), p.3659-3678

2021

Volltextzugriff (PDF)

Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells

Molecular cancer therapeutics, 2009-11, Vol.8 (11), p.3162-3170

2009

Volltextzugriff (PDF)

MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells

Frontiers in oncology, 2023-08, Vol.13, p.1220459-1220459

2023

Volltextzugriff (PDF)

The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737

Molecular cancer therapeutics, 2017-01, Vol.16 (1), p.102-115

2017

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(48)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

18 F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer

Acquisition of chemoresistance in a human ovarian carcinoma cell line is linked to a defect in cell cycle control

Altered adhesion properties and alpha v integrin expression in a cisplatin‐resistant human ovarian carcinoma cell line

Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route

Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumour drugs

Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulation

Citrate induces apoptotic cell death: a promising way to treat gastric carcinoma?

Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma

The cyclin-dependent kinase inhibitor p21(cip1/waf1) enhances the cytotoxicity of ganciclovir in HSV-tk transfected ovarian carcinoma cells

Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells

Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease

Effect of 2-Deoxy-D-glucose on Various Malignant Cell Lines In Vitro

Effect of Citrate on Malignant Pleural Mesothelioma Cells: A Synergistic Effect with Cisplatin

Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant Recipients

Functional miRNA screening identifies wide-ranging antitumor properties of miR-3622b-5p and reveals a new therapeutic combination strategy in ovarian tumor organoids

Identification of predictive factors of response to the BH3‐mimetic molecule ABT‐737: An ex vivo experiment in human serous ovarian carcinoma

Identifying patients eligible for PARP inhibitor treatment: from NGS-based tests to 3D functional assays

Impact of automated methods for quantitative evaluation of immunostaining: Towards digital pathology

The influence of long non-coding RNAs on the response to chemotherapy in ovarian cancer

Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin

Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk

The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels

Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells

MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells

The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737

Aktive Filter

Suchergebnisse filtern